Cargando…

Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022

INTRODUCTION: Reviews of randomized clinical trials (RCTs) in dementia with Lewy bodies (DLB) are essential for informing ongoing research efforts of symptomatic therapies and potentially disease-modifying therapies (DMTs). METHODS: We performed a systematic review of all clinical trials conducted u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelnour, Carla, Gonzalez, Maria Camila, Gibson, Lucy L., Poston, Kathleen L., Ballard, Clive G., Cummings, Jeffrey L., Aarsland, Dag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195935/ https://www.ncbi.nlm.nih.gov/pubmed/37017910 http://dx.doi.org/10.1007/s40120-023-00467-8

Ejemplares similares

Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
por: Gibson, Lucy L., et al.
Publicado: (2023)

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
por: Stubendorff, Kajsa, et al.
Publicado: (2014)

Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications
por: Mueller, Christoph, et al.
Publicado: (2017)

((123)I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study
por: Siepel, Françoise J, et al.
Publicado: (2013)

Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study
por: Rongve, A, et al.
Publicado: (2016)

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias
por: Howlett, David R., et al.
Publicado: (2014)

Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia
por: Vallortigara, Julie, et al.
Publicado: (2014)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer’s disease but not Lewy body dementias
por: Chai, Yuek Ling, et al.
Publicado: (2023)

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations
por: Rodriguez-Porcel, Federico, et al.
Publicado: (2022)

Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies
por: Petrova, Mariya, et al.
Publicado: (2015)

Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations
por: Rodriguez-Porcel, Federico, et al.
Publicado: (2022)

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies
por: Abdelnour, Carla, et al.
Publicado: (2020)

Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data
por: Abdelnour, Carla, et al.
Publicado: (2022)

Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias
por: Xing, Huayang, et al.
Publicado: (2016)

Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia
por: Alghamdi, Amani, et al.
Publicado: (2017)

Mental health of people living with dementia in care homes during COVID-19 pandemic
por: Velayudhan, Latha, et al.
Publicado: (2020)

Structural synaptic signatures of Alzheimer's disease and dementia with Lewy bodies in the male brain
por: Glebov, Oleg O., et al.
Publicado: (2022)

Decreased DHA‐containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ(42), phosphorylated α‐synuclein, and synaptopathology
por: Chong, Joyce R., et al.
Publicado: (2023)

Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 Update
por: Rogowska, Marianna, et al.
Publicado: (2022)

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson’s disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2013)

Research criteria for the diagnosis of prodromal dementia with Lewy bodies
por: McKeith, Ian G., et al.
Publicado: (2020)

A Longitudinal Study of Neurocognition in Dementia with Lewy Bodies Compared to Alzheimer’s Disease
por: Breitve, Monica H., et al.
Publicado: (2018)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
por: Mulugeta, Ezra, et al.
Publicado: (2011)

Body mass index trajectories and associations with cognitive decline in people with Lewy body dementia and Alzheimer's disease
por: Borda, Miguel G., et al.
Publicado: (2022)

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
por: Berge, Guro, et al.
Publicado: (2014)

A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
por: Breitve, Monica H, et al.
Publicado: (2014)

A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer’s disease
por: Breitve, Monica H., et al.
Publicado: (2016)

The importance of co-pathologies on neuropsychiatric symptoms in dementia
por: Gibson, Lucy L., et al.
Publicado: (2022)

White Matter Hyperintensities in Mild Lewy Body Dementia
por: Oppedal, K., et al.
Publicado: (2012)

Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group
por: D'Antonio, Fabrizia, et al.
Publicado: (2021)

Apathy is associated with faster global cognitive decline and early nursing home admission in dementia with Lewy bodies
por: Breitve, Monica H., et al.
Publicado: (2018)

Sex differences in grey matter networks in dementia with Lewy bodies
por: Habich, Annegret, et al.
Publicado: (2023)

Comorbidity profile in dementia with Lewy bodies versus Alzheimer’s disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2014)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Association Between Amygdala Volume and Trajectories of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia With Lewy Bodies
por: Jaramillo-Jimenez, Alberto, et al.
Publicado: (2021)

CD4(+) T cells contribute to neurodegeneration in Lewy body dementia
por: Gate, David, et al.
Publicado: (2021)

RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus
por: O’Brien, John T., et al.
Publicado: (2022)

Sex differences in brain atrophy in dementia with Lewy bodies
por: Oltra, Javier, et al.
Publicado: (2023)

Prodromal Dementia With Lewy Bodies and Recurrent Panic Attacks as the First Symptom: A Case Report
por: Jaramillo-Jimenez, Alberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_64mjc9aabq4l4chsitqdqc1ki2